Priority Date: 21.09.11 (US 201161537099P)

NOVEL BETULINIC ACID DERIVATIVES WITH ANTIVIRAL ACTIVITY

  • Application ID: EP12766825
  • Status: PATENT GRANTED

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
2 offices
Technology Company
Employment test 11 - 50 employees
Company dna reitstotter kinzebach and partner
operating since 1928
Headquarter in Munich, Berlin and 1 office
active in Legal Services

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Reitstötter Kinzebach & Partner GbR and GlaxoSmithKline are specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 231 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 21.09.2011 - Priority Date (US 201161537099P)
  • 28.03.2013 - Publication A1 (WO2013043778)
  • 30.07.2014 - Publication A1 (EP2758419)
  • 19.10.2016 - Publication B1 (EP2758419)
  • 19.04.2017 - Publication B8 (EP2758419)

IPC Classification